The Only Sleep Study I Can Get Is a PAT Aaron B. Holley, MD +++++

The Only Sleep Study I Can Get Is a PAT Aaron B. Holley, MD https://www.medscape.com/viewarticle/only-sleep-study-i-can-get-pat-2026a1000jab?ecd=wnl_edit_tpal_etid8422209&uac=148436CN&impID=8422209 Twenty years ago, high reimbursement rates for in-lab polysomnograms (PSGs) gave sleep labs a license to print money. Labs proliferated like tags on a viral tweet. Thanks to the American Academy of Sleep Medicine’s (AASM) efforts to ensure everyone has sleep apnea (OSA), the resulting capacity still couldn’t meet the demand. The sleep field was winning, but patients and payors were not. Getting Into a Medical Residency Is Harder Than Ever, Here’s Why June 12, 2026 Every March, thousands of newly minted doctors find out in a single anxious moment — Match Day — whether they have a job. Most do. But in the most competitive specialties, nearly 1 in 3 qualified applicants walks away empty-handed according to The 10 Most Competitive Medical Residencies Report 2026. And the bar keeps rising. https://www.medscape.com/viewarticle/getting-medical-residency-harder-than-ever-heres-why-2026a1000jw0?ecd=wnl_edit_tpal_etid8422209&uac=148436CN&impID=8422209 Multidisciplinary Teams Could Ease Australia’s Urgent Care Workforce Concerns John Adie, MB, ChB, PhD For Australia’s healthcare system to be sustainable, as much care as possible must be moved from secondary care to primary care, and from primary care to nursing, paramedicine, and allied health professionals. This practical realization comes from my training, specialization, and work in New Zealand’s integrated primary care clinic (IPCC) and urgent care clinic (UCC) models as well as in Australian rural and remote medicine models. In these models, many patients with non-life-threatening urgent conditions are managed in community settings by multidisciplinary teams at a lower cost and less wait than if they were managed in hospital emergency departments. https://www.medscape.com/viewarticle/multidisciplinary-teams-could-ease-australias-urgent-care-2026a1000ix9?ecd=wnl_edit_tpal_etid8422209&uac=148436CN&impID=8422209 Chemo-Free Therapy in Pediatric Acute Promyelocytic Leukemia Cristina Ferrario STOCKHOLM —Eliminating anthracyclines from the treatment regimen of children and adolescents newly diagnosed with acute promyelocytic leukemia (APL) is feasible and yields excellent positive outcomes in standard-risk and high-risk patients, new data suggest. At the 2026 European Hematology Association Congress, Franco Locatelli presented the final results of the ICC-APL-02 trial, paving the way for a new treatment approach that dispenses with conventional chemotherapy in this pediatric population. https://www.medscape.com/viewarticle/chemo-free-therapy-pediatric-acute-promyelocytic-leukemia-2026a1000jvy?ecd=wnl_edit_tpal_etid8422209&uac=148436CN&impID=8422209 Fast Five Quiz: Melanoma Practice Essentials Reviewed by William James, MD; Maurie Markman, MD https://reference.medscape.com/viewarticle/fast-five-quiz-melanoma-practice-essentials-2025a1000e9k?ecd=wnl_edit_tpal_etid8422209&uac=148436CN&impID=8422209 Melanoma is an aggressive malignant tumor of melanocytes responsible for the vast majority of skin cancer-related mortality. Mastering practice essentials such as appropriate diagnostic biopsy technique, accurate assessment of Breslow thickness, evidence-based use of sentinel lymph node biopsy, and stage-appropriate imaging is critical to avoid understaging, optimize prognostication, and guide timely surgical and systemic management.